Status: Recruiting
Registry Platform Ovarian and Endometrial Cancer
The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with advanced or metastatic ovarian cancer (OC) or advanced or metastatic endometrial cancer (EC) in Germany.
Participants needed: 1,975
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: iOMEDICO AGUpdated: Jan 28, 2026Locations: 1Duration: 3 Years
Eligibility criteria
patients with FIGO stage IIb-IV OC who are starting systemic treatment or [+4]
newly diagnosed early-stage OC (FIGO stage I-IIa) [+2]